M Wang1, N Cheng2, S Zheng1, D Wang3, X Hu1, X Ren1, H Pei1, H Ma4, H Mu4, Y Bai1. 1. a School of Public Health, Lanzhou University , Lanzhou , Gansu , China ; 2. b College of Basic Medicine, Lanzhou University , Lanzhou , Gansu , China ; 3. c Department of Environmental Health Sciences , School of Public Health, Yale University , New Haven , CT , USA ; 4. d Jinchuan Worker's Hospital , Jinchang , Gansu , China.
Abstract
OBJECTIVE: To determine whether metabolic syndrome (MetS) and its components are risk factors for breast cancer among postmenopausal women in China. METHODS: Based on the baseline data of the Jinchang Cohort, a case-control study was carried out among postmenopausal women, including 43 cases and 86 controls. Both MetS and its components were evaluated. Odds ratios and 95% confidence intervals (CI) for the association were estimated by conditional logistic regression analysis. RESULTS: The odds ratio of postmenopausal breast cancer was 3.505 (95% CI 1.282-9.583) for MetS, 3.016 (95% CI 1.044-8.715) for body mass index (BMI) ≥ 25 kg/m(2), and 3.191 (95% CI 1.253-8.125) for dyslipidemia. There was no significant association between postmenopausal breast cancer and hypertension as well as diabetes. Women with four metabolic factors showed greater risk for postmenopausal breast cancer (p(trend) < 0.05). Dyslipidemia and BMI ≥ 25 kg/m(2) showed most significant interaction on breast cancer (odds ratio = 11.359; 95% CI 2.663-48.450). With BMI ≥ 25 kg/m(2), the interaction of dyslipidemia and other metabolic factors on breast cancer was higher than that without BMI ≥ 25 kg/m(2). CONCLUSION: This case-control study suggested that MetS was associated with an elevated risk of breast cancer among postmenopausal women in north-west China. Overweight and dyslipidemia had the strongest adverse effects on postmenopausal breast cancer.
OBJECTIVE: To determine whether metabolic syndrome (MetS) and its components are risk factors for breast cancer among postmenopausal women in China. METHODS: Based on the baseline data of the Jinchang Cohort, a case-control study was carried out among postmenopausal women, including 43 cases and 86 controls. Both MetS and its components were evaluated. Odds ratios and 95% confidence intervals (CI) for the association were estimated by conditional logistic regression analysis. RESULTS: The odds ratio of postmenopausal breast cancer was 3.505 (95% CI 1.282-9.583) for MetS, 3.016 (95% CI 1.044-8.715) for body mass index (BMI) ≥ 25 kg/m(2), and 3.191 (95% CI 1.253-8.125) for dyslipidemia. There was no significant association between postmenopausal breast cancer and hypertension as well as diabetes. Women with four metabolic factors showed greater risk for postmenopausal breast cancer (p(trend) < 0.05). Dyslipidemia and BMI ≥ 25 kg/m(2) showed most significant interaction on breast cancer (odds ratio = 11.359; 95% CI 2.663-48.450). With BMI ≥ 25 kg/m(2), the interaction of dyslipidemia and other metabolic factors on breast cancer was higher than that without BMI ≥ 25 kg/m(2). CONCLUSION: This case-control study suggested that MetS was associated with an elevated risk of breast cancer among postmenopausal women in north-west China. Overweight and dyslipidemia had the strongest adverse effects on postmenopausal breast cancer.
Entities:
Keywords:
BREAST CANCER; CASE–CONTROL STUDY; CHINA; METABOLIC SYNDROME; POSTMENOPAUSAL
Authors: Tae Ho Kim; Jae Seung Chang; Kyu-Sang Park; Jeeyeon Park; Nahyun Kim; Jong In Lee; In Deok Kong Journal: PLoS One Date: 2017-02-08 Impact factor: 3.240
Authors: Michael S Simon; Jennifer L Beebe-Dimmer; Theresa A Hastert; JoAnn E Manson; Elizabeth M Cespedes Feliciano; Marian L Neuhouser; Gloria Y F Ho; Jo L Freudenheim; Howard Strickler; Julie Ruterbusch; Ana Barac; Rowan Chlebowski; Bette Caan Journal: Cancer Date: 2018-01-16 Impact factor: 6.860